BrightPath Biotherapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 12.5%.

Top 19 shareholders own 10.57% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
1.1%	Matsui Securities Co. Ltd., Asset Management Arm	778,600	JP¥45.9m	0%	0.21%
1.09%	Macquarie Group, Ltd., Banking & Securities Investments	768,500	JP¥45.3m	5.25%	no data
1.04%	Rakuten Investment Management, Inc.	738,500	JP¥43.6m	0%	0.01%
0.64%	Mitsubishi UFJ Capital Co., Ltd.	450,000	JP¥26.5m	0%	0.17%
0.57%	Hiroshi Akeo	400,000	JP¥23.6m	0%	no data
0.55%	Takehiko Nakazato	390,300	JP¥23.0m	0%	no data
0.53%	Shunsuke Nakamura	373,000	JP¥22.0m	0%	no data
0.51%	Akira Nishimura	360,000	JP¥21.2m	0%	no data
0.5%	Kazuhiko Kaneko	355,300	JP¥21.0m	0%	no data
0.47%	SBI Holdings Inc., Asset Management Arm	332,494	JP¥19.6m	0%	0.01%
0.46%	Shinaaki Katsura	327,200	JP¥19.3m	0%	no data
0.45%	Takeshi Kishima	317,500	JP¥18.7m	0%	no data
0.44%	Morgan Stanley, Investment Banking and Brokerage Investments	308,300	JP¥18.2m	-182%	no data
0.43%	Monex Group, Inc., Asset Management Arm	301,684	JP¥17.8m	0%	0.3%
0.43%	Japan Securities Finance Co. Ltd., Asset Management Arm	301,000	JP¥17.8m	0%	no data
0.4%	au Kabucom Securities Co., Ltd., Asset Management Arm	281,200	JP¥16.6m	0%	0.07%
0.38%	Jikei Co.,Ltd.	270,000	JP¥15.9m	0%	no data
0.34%	Kenichi Nagai	240,000	JP¥14.2m	0%	no data
0.26%	Akira Yamada	185,000	JP¥10.9m	0%	no data